Momentum

Relative Strength (%)
1m-7.82%
3m
6m
1yr
Volume Change (%)
10d/3m
Price vs... (%)
52w High-73.08%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Neovasc EPS forecast chart

Profile Summary

Neovasc Inc. is a Canada-based specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's products include the Neovasc ReducerTM (Reducer), for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle and the TiaraTM (Tiara), for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. Its wholly owned subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc.

Directors

Last Annual
December 31st, 2020
Last Interim
September 30th, 2021
Incorporated
April 19th, 2002
Public Since
May 23rd, 2001
No. of Employees
71
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
67,587,079

NVCN Share Price Performance

Latest News for NVCN

Upcoming Events for NVCN

Neovasc Inc at Sidoti & Company December Micro Cap Conference (Virtual)

Q4 2021 Neovasc Inc Earnings Release

Q1 2022 Neovasc Inc Earnings Release

Similar to NVCN

Picture of Accelerate Diagnostics logo

Accelerate Diagnostics

us flag iconNASDAQ Capital Market

Picture of Adapthealth logo

Adapthealth

us flag iconNASDAQ Capital Market

Picture of Aethlon Medical logo

Aethlon Medical

us flag iconNASDAQ Capital Market

Agendia NV

us flag iconNASDAQ Capital Market

Picture of Allied Healthcare Products logo

Allied Healthcare Products

us flag iconNASDAQ Capital Market

FAQ

Or unlock with your email

Or unlock with your email